Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Precision medicine enhances personalized medicine in cardiology].

Innere Medizin (Heidelberg, Germany)·2024
Same author

[Cardiac amyloidosis].

Innere Medizin (Heidelberg, Germany)·2023
Same author

Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation.

Clinical research in cardiology : official journal of the German Cardiac Society·2023
Same author

Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction.

ESC heart failure·2021
Same author

[Less is more in cardiology and angiology].

Der Internist·2021
Same author

[Primary care medicine-Part II : Practice-oriented diagnosis and treatment pathways].

Der Internist·2021

相关实验视频

Updated: Jul 12, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

在患有充血性心力衰竭的患者中,冠心内皮鲁瓦酸的血液动力学影响:一项开放性研究.

H P Hermann1, B Pieske, E Schwarzmüller

  • 1Zentrum Innere Medizin, Abteilung Kardiologie und Pneumologie, Universität Göttingen, Germany.

Lancet (London, England)
|April 28, 1999
PubMed
概括
此摘要是机器生成的。

在患有充血性心力衰竭的患者中,冠状病毒内皮鲁瓦酸的使用显著改善了心脏功能,增加了心脏指数和中风体积指数. 这项研究突出了pyruvate的重要性.

更多相关视频

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

相关实验视频

Last Updated: Jul 12, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

科学领域:

  • 心脏病学 心脏病学
  • 生物化学 生物化学
  • 代谢途径 代谢途径

背景情况:

  • 酸盐是一种关键的克雷布斯循环中间体,对心肌能量产生至关重要.
  • 它在各种条件下 (正常,缺氧,缺血后) 在动物模型中增强收缩性.

研究的目的:

  • 为了评估血液动力学效应的冠心内皮鲁瓦特在人类患有充血性心力衰竭的患者.

主要方法:

  • 八名患有扩张性心肌病的患者接受了血液动力学测量.
  • 给左侧冠状动脉注入两次15分钟的pyruvate输液.
  • 测量结果在输入pyruvate和液冲洗后进行了比较.

主要成果:

  • 酸盐输注使心脏指数增加了23% (p<0.05) 和中风体积指数增加了38% (p<0.05).
  • 肺毛细管压力下降了36% (p<0.05),心率下降了11%.
  • 在输液停止后,影响在很大程度上是可逆的.

结论:

  • 酸盐在人类心力衰竭中表现出有利的内性质.
  • 需要进一步研究替代的施用方法.